CPUY074020

Research use only, not for human use.

CPUY074020 is a potent and orally bioavailable inhibitor of histone methyltransferase G9a (IC50: 2.18 μM) with anti-proliferative activity.

CPUY074020 is a potent and oral bioavailable inhibitor of histone methyltransferase G9a, with an IC50 of 2.18 μM. CPUY074020 possesses anti-proliferative activity.

CPUY074020 (2-8μM; 24 hours) induces cell death through apoptosis.CPUY074020 (2.5-10μM ; 48 hours) dose-dependently de-regulates H3K9 trimethylation.Apoptosis Analysis Cell Line:MCF-7 cells Concentration:2 μM, 4 μM, 8 μM Incubation Time:24 hours Result:Induced MCF-7 cells apoptosis.Western Blot Analysis Cell Line: MCF-7 cells Concentration:2.5 μM, 5 μM, 10 μM Incubation Time:48 hours Result:Dose-dependently de-regulated H3K9 trimethylation.

CPUY074020 exhibits reasonable PK properties, with an oral bioavailability of 55.5% and a T1/2 value of 4.0 hours at an oral dose of 10 mg/kg.Animal Model:Mice Dosage:10 mg/kg Administration:Oral administration Result:t1/2=4.0 hours

——

Others

Other Targets

Histone Methyltransferase

——

——

902279-44-1

416.52

C25H28N4O2

>98% (HPLC)

——

N(CCN1CCCC1)C2=C3C=4C(C(=C2)N5CCCCC5)=NOC4C=6C(C3=O)=CC=CC6

——

(-20℃)

With Ice Pack

≥ 2 years